| |
| |
|
| Insider
Information: |
Perceptive Advisors Llc |
| Relationship: |
10% Owner |
| City: |
Washington |
| State: |
DC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
225,000 |
|
|
Indirect Shares
|
13,701,348 |
|
|
| Direct
Value |
$15,131,250 |
|
|
|
Indirect Value
|
$116,469,250 |
|
|
| Total
Shares |
13,926,348 |
|
|
| Total
Value |
$131,600,500 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
2
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-2.0
|
0.0
|
| Percentage
Gain/Loss : |
 -100.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
ANI Pharmaceuticals Inc |
ANIP |
10% Owner |
2004-12-03 |
225,000 |
2004-12-03 |
209,100 |
Premium* |
|
|
Cypress Bioscience Inc |
CYPB |
Managing Member |
2003-05-01 |
0 |
2003-07-16 |
989,263 |
Premium* |
|
|
Antares Pharma Inc |
ATRS |
10% Owner |
|
0 |
2004-02-06 |
2,700,000 |
Premium* |
|
|
Miravant Medical Technologies |
MRVT |
10% Owner |
2004-06-08 |
0 |
2004-06-18 |
53,890 |
Premium* |
|
|
Penwest Pharmaceuticals Co |
PPCO |
10% Owner |
2008-12-24 |
0 |
2010-09-20 |
6,476,446 |
Premium* |
|
|
Zogenix, Inc. |
ZGNX |
10% Owner |
|
0 |
2017-05-05 |
3,272,649 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ZGNX |
Zogenix, Inc. |
10% Owner |
– – • |
2017-05-05 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,272,649 |
|
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
10% Owner |
– – • |
2010-09-20 |
4 |
D |
$5.00 |
$32,382,230 |
I/I |
(6,476,446) |
6,476,446 |
0 |
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
10% Owner |
– – • |
2009-03-06 |
4 |
D |
$1.26 |
$345,696 |
I/I |
(274,362) |
6,476,446 |
0 |
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
10% Owner |
– – • |
2009-01-30 |
4 |
D |
$1.75 |
$4,025 |
I/I |
(2,300) |
6,750,808 |
0 |
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
10% Owner |
– – • |
2009-01-16 |
4 |
B |
$5.00 |
$119,500 |
I/I |
23,900 |
6,753,108 |
1.5 |
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
10% Owner |
– – • |
2009-01-06 |
4 |
B |
$5.00 |
$125,000 |
I/I |
25,000 |
6,729,208 |
1.5 |
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
10% Owner |
– – • |
2008-12-29 |
4 |
B |
$5.00 |
$11,500 |
I/I |
2,300 |
6,704,208 |
1.5 |
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
10% Owner |
– – • |
2008-12-29 |
4 |
B |
$5.00 |
$23,500 |
I/I |
4,700 |
6,701,908 |
1.5 |
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
10% Owner |
– – • |
2008-12-24 |
4 |
A |
$1.26 |
$345,696 |
I/I |
274,362 |
6,697,208 |
0 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
10% Owner |
– – • |
2004-12-03 |
4 |
S |
$4.35 |
$6,558,225 |
I/I |
(1,395,000) |
209,100 |
|
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
10% Owner |
– – • |
2004-12-02 |
4 |
B |
$3.98 |
$7,960 |
I/I |
2,000 |
1,877,650 |
1.5 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
10% Owner |
– – • |
2004-12-02 |
4 |
S |
$4.47 |
$1,798,000 |
I/I |
(400,000) |
1,604,100 |
|
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
10% Owner |
– – • |
2004-10-08 |
4 |
B |
$9.87 |
$156,857 |
I/I |
15,900 |
1,973,550 |
1.5 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
10% Owner |
– – • |
2004-10-07 |
4 |
B |
$10.11 |
$101,071 |
I/I |
10,000 |
1,958,650 |
1.5 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
10% Owner |
– – • |
2004-10-06 |
4 |
B |
$9.90 |
$99,013 |
I/I |
10,000 |
1,949,650 |
1.5 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
10% Owner |
– – • |
2004-10-05 |
4 |
B |
$9.90 |
$173,247 |
I/I |
17,500 |
1,940,650 |
1.5 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
10% Owner |
– – • |
2004-10-04 |
4 |
B |
$9.72 |
$140,950 |
I/I |
14,500 |
1,924,850 |
1.5 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
10% Owner |
– – • |
2004-10-01 |
4 |
B |
$9.59 |
$206,185 |
I/I |
21,500 |
1,911,750 |
1.5 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
10% Owner |
– – • |
2004-09-30 |
4 |
B |
$8.96 |
$89,645 |
I/I |
10,000 |
1,892,350 |
1.5 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
10% Owner |
– – • |
2004-09-14 |
4 |
B |
$7.69 |
$188,287 |
I/I |
24,500 |
1,883,350 |
1.5 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
10% Owner |
– – • |
2004-09-13 |
4 |
B |
$7.17 |
$185,654 |
I/I |
25,900 |
1,861,250 |
1.5 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
10% Owner |
– – • |
2004-09-09 |
4 |
B |
$6.85 |
$32,195 |
I/I |
4,700 |
1,837,850 |
1.5 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
10% Owner |
– – • |
2004-08-31 |
4 |
B |
$6.84 |
$61,563 |
I/I |
9,000 |
1,833,550 |
1.5 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
10% Owner |
– – • |
2004-08-30 |
4 |
B |
$6.84 |
$68,374 |
I/I |
10,000 |
1,824,550 |
1.5 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
10% Owner |
– – • |
2004-08-19 |
4 |
B |
$5.84 |
$40,328 |
I/I |
6,900 |
12,450 |
1.5 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
